Antitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinomaZhimin Tong(Austin College), Dipen M. Maru(The University of Texas MD Anderson Cancer Center)OncotargetFebruary 23, 201710.18632/oncotarget.15645Cited by 19SaveCiteExport RISWatch citationsRelated PapersIncreased expression of the lipocalin 24p3 as an apoptotic mechanism for MK886|Biochemical Journal|2003|48Targeting cyclin-dependent kinase 9 by a novel inhibitor enhances radiosensitization and identifies Axl as a novel downstream target in esophageal adenocarcinoma|Oncotarget|2019|13